|
Program and Session Facilitators |
||||
| Time |
Day 1 |
Day 2 |
Day 3 |
Day 4 |
|
|
||||
| 9:00 – 10:30 |
Introduction and Course Overview Dr Vasantha Muthuswamy – ICMR Dr Peter A. Singer – University of Toronto Dr Abdallah S. Daar – University of Toronto |
Ethical guidelines for Medical Research in India Dr N.K. Ganguly – ICMR |
Intellectual Property Rights Dr Malathi Lakshmikumaran – TERI |
Opinion Leaders' Network Dr Peter A. Singer Dr Rakesh Dubey – Ocimum Biosolutions |
| 11:00–12:30 |
New Science 1 : Genomics Dr S. S. Agarwal – ACTREC DNA Vaccines – Relevance for India Dr G. Padmanabhan – IISc |
Business Models Dr Chandu Nair – Scope Marketing & Knowledge National Systems of Innovation Dr Peter A. Singer |
Public Health – Community Ownership Dr Saraswathi Sankaran – DESH |
|
| 2:00–3:30 |
New Science 2 : Stem Cells Dr Dipika Mohanty – ICMR (Institute of Immunohaematology) |
Indian Business Perspectives Mr Khalil Ahmed – Shanta Biotech Dr Krishna Ella – Bharath Biotech |
Group Presentations Biotechnology: From Benches to Bedside Dr Rajesh Behl – Centre for Human Genetics |
Group Presentations |
| 4:00–5:30 |
Genomics and Global Health Dr Abdallah S. Daar |
Pharmaco-genomics Dr C. M. Gupta – CDRI Dr Vasantha Muthuswamy Dr R. H. Jani – German Remedies |
Legal Regulations of Genomics – Emerging Scenario Dr Madhava Menon – WB National University of Juridical Sciences |
Summing up Dr Sandhya Tewari – CII Discussion & Closing – Dr Peter A. Singer |
Acharya et al. Health Research Policy and Systems 2004 2:1 doi:10.1186/1478-4505-2-1 |
||||